EBRAHIMI, A. Et Al. 2024. Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review. ACS Pharmacology and Translational Science , vol.7, no.11 , 3299-3333.

EBRAHIMI, A., AK, G., ÖZEL, C., İzgördü, H., GHORBANPOOR, H., Hassan, S., ... AVCI, H.(2024). Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review. ACS Pharmacology and Translational Science , vol.7, no.11, 3299-3333.

EBRAHIMI, ALIAKBAR Et Al. "Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review," ACS Pharmacology and Translational Science , vol.7, no.11, 3299-3333, 2024

EBRAHIMI, ALIAKBAR Et Al. "Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review." ACS Pharmacology and Translational Science , vol.7, no.11, pp.3299-3333, 2024

EBRAHIMI, A. Et Al. (2024) . "Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review." ACS Pharmacology and Translational Science , vol.7, no.11, pp.3299-3333.

@article{article, author={ALIAKBAR EBRAHIMI Et Al. }, title={Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review}, journal={ACS Pharmacology and Translational Science}, year=2024, pages={3299-3333} }